Wed, April 13, 2011
[ Wed, Apr 13th 2011 ]: Market Wire
Tenet Healthcare Joins the Obama Administrationa?s Partnership for Patients
[ Wed, Apr 13th 2011 ]: Market Wire
Humana Military and Military Warriors Support Fou .. ll, and Injured Service Members at 2011 Valero Te
[ Wed, Apr 13th 2011 ]: Market Wire
Magellan Health Services Releases 2010 Annual Report
[ Wed, Apr 13th 2011 ]: Market Wire
Orthovita Launches the Aliquot Directional Bone Tamp
[ Wed, Apr 13th 2011 ]: Market Wire
Seattle Genetics Announces Tenth Collaborator ADC Program in Clinical Development
[ Wed, Apr 13th 2011 ]: Market Wire
Stellar Pharmaceuticals Inc. and Watson Pharmaceu .. minate Uracyst(R) Supply and Licensing Agreements
[ Wed, Apr 13th 2011 ]: Market Wire
Allezoe Medical Holdings Announces Resignation from Subsidiary Board
[ Wed, Apr 13th 2011 ]: Market Wire
New Corporate Strategy; Ball Named Interim Chairman; Revenue Projections
[ Wed, Apr 13th 2011 ]: Market Wire
Amica Mature Lifestyles Announces Third Quarter R .. Fiscal 2011 and Announces Fourth Quarter Dividend
[ Wed, Apr 13th 2011 ]: Market Wire
XenoPort Announces Presentation of Preclinical Da .. XP23829 at the 63rd Annual Meeting of the America
[ Wed, Apr 13th 2011 ]: Market Wire
Volatility Persists for Xoma and Aastrom Biosciences
[ Wed, Apr 13th 2011 ]: Market Wire
Unigene Increases Support for Tarsa in Preparation for Oral Calcitonin NDA Submission
[ Wed, Apr 13th 2011 ]: Market Wire
Celsion Announces Issuance of U.S. Patent Covering ThermoDox(R) Technologies
[ Wed, Apr 13th 2011 ]: Market Wire
Amunix Signs Research Collaboration With Biogen I .. ext Generation Long-Lasting Blood Factor Products
[ Wed, Apr 13th 2011 ]: Market Wire
BioSante Pharmaceuticals Announces Teva New Drug Application for Bio-T-Gela"
[ Wed, Apr 13th 2011 ]: Market Wire
Implant Sciences Announces Explosives Trace Detection Pioneer Dr. William McGann as Advisor
Tue, April 12, 2011
[ Tue, Apr 12th 2011 ]: Market Wire
A Biogen Idec beszmolt a sclerosis multiplex keze .. fumarate) szer elso 3-as fzis klinikai tesztj©ne
[ Tue, Apr 12th 2011 ]: Market Wire
Fero Industries Appoints Lopez as Chief Operating Officer
[ Tue, Apr 12th 2011 ]: Market Wire
Cerus to Release First Quarter 2011 Results on April 28, 2011
[ Tue, Apr 12th 2011 ]: Market Wire
Marina Biotech Announces Patent Allowance for Its Proprietary Nucleic Acid Delivery Technology
[ Tue, Apr 12th 2011 ]: Market Wire
Rich Pipelines Send Biotech Stocks Soaring
[ Tue, Apr 12th 2011 ]: Market Wire
La continua dedicacin de Biogen Idec con las pers .. mltiple se evidencia en los datos presentados du
[ Tue, Apr 12th 2011 ]: Market Wire
dermaPACE Pivotal Phase III Clinical Trial Result .. atment to Be Presented at the Symposium on Advanc
[ Tue, Apr 12th 2011 ]: Market Wire
Zynex Prepares for First Clinical Evaluation of Blood Volume Monitor Medical Device
[ Tue, Apr 12th 2011 ]: Market Wire
UnitedHealth Group anuncia la marca principal "Optum" para sus empresas de servicios sanitarios
[ Tue, Apr 12th 2011 ]: Market Wire
Teleflex Announces First Quarter 2011 Conference Call Information
[ Tue, Apr 12th 2011 ]: Market Wire
Skystar Bio-Pharmaceutical Reports Record Fourth Quarter and Fiscal Year 2010 Financial Results
[ Tue, Apr 12th 2011 ]: Market Wire
Das fortgesetzte Engagement von Biogen Idec fr Me .. uf der 63. Jahrestagung der amerikanischen Academ
[ Tue, Apr 12th 2011 ]: Market Wire
AVEO Pharmaceuticals Appoints Henri A. Termeer to its Board of Directors
[ Tue, Apr 12th 2011 ]: Market Wire
Le d©vouement constant de Biogen Idec envers les .. en plaques est illustr© par les donn©es pr©sen
[ Tue, Apr 12th 2011 ]: Market Wire
Illumina to Announce First Quarter 2011 Financial Results on Tuesday, April 26, 2011
[ Tue, Apr 12th 2011 ]: Market Wire
Merck & Co., Inc., und Sun Pharma grnden Joint Ve .. marktung neuartiger Formulierungen und Kombinatio
Mon, April 11, 2011
[ Mon, Apr 11th 2011 ]: Market Wire
Biogen Idec oglasza pozytywne podsumowanie wynikw .. azy 3 badan nad doustnym BG-12 (FUMARAN DIMETYLU)
[ Mon, Apr 11th 2011 ]: Market Wire
Biogen Idec maakt positief eerste resultaat beken .. k naar orale BG-12 (DIMETHYLFUMARAAT) bij Multipl
[ Mon, Apr 11th 2011 ]: Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Breaches of Fiduciary Duty by the Board of Americ
[ Mon, Apr 11th 2011 ]: Market Wire
American Medical Systems Shareholder Investigatio .. rm Concerning Acquisition by Endo Pharmaceuticals
[ Mon, Apr 11th 2011 ]: Market Wire
UnitedHealth Group fhrt Gesundheitsleistungen unter Dachmarke aOptuma zusammen
[ Mon, Apr 11th 2011 ]: Market Wire
Aetna Releases 2010 Annual Report, aEmbracing Change, Engaging Peoplea?
[ Mon, Apr 11th 2011 ]: Market Wire
CML HealthCare Inc. to Host Annual General Meeting on May 19, 2011
[ Mon, Apr 11th 2011 ]: Market Wire
Prana Secures Key PBT2 Patent in Japan and Completes Core IP Suite
[ Mon, Apr 11th 2011 ]: Market Wire
Kendall Law Group Investigates American Medical Systems Holdings Inc. Acquisition for Shareholders
[ Mon, Apr 11th 2011 ]: Market Wire
Orthovita Announces Presentation of Clinical Resu .. ical Hemostat in Reducing Blood Loss During Prima
[ Mon, Apr 11th 2011 ]: Market Wire
CytRx Receives Shares of ADVENTRX Pharmaceuticals in SynthRx Transaction
[ Mon, Apr 11th 2011 ]: Market Wire
PPD to Present at World Vaccine Congress 2011
[ Mon, Apr 11th 2011 ]: Market Wire
Immunovaccine Reports Positive Interim Data from .. -0907 in Patients With Breast, Ovarian and Prosta
[ Mon, Apr 11th 2011 ]: Market Wire
Biogen Idec meldet positive Topline-Ergebnisse au .. ur Prfung von oral verabreichtem BG-12 (DIMETHYLF
[ Mon, Apr 11th 2011 ]: Market Wire
Impax Laboratories Confirms Patent Challenge Rela .. to OXYCONTIN® 10, 15, 20, 30, 40, 60, and 80 mg
[ Mon, Apr 11th 2011 ]: Market Wire
UnitedHealth Group Announces aOptuma Master Brand for Its Health Services Businesses

La continua dedicacin de Biogen Idec con las personas que viven con esclerosis mltiple se evidencia en los datos presentados du

WESTON, Mass.--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) ha comunicado que los datos que evidencian el esfuerzo e iniciativa de la empresa para abordar las necesidades de las personas que viven con esclerosis mltiple (MS, en sus siglas en ingl©s) sern presentados durante la 63 edicin de la reunin anual de la American Academy of Neurology (AAN) en Honolulu, del 9 al 16 de abril, 2011.

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.